LUNG NEOPLASM MALIGNANT

This adverse event was reported 41143 times

These drugs are most commonly taken by patients reporting LUNG NEOPLASM MALIGNANT:

# Drug Count
0 RANITIDINE 6760
1 RANITIDINE HYDROCHLORIDE 1963
2 TIOTROPIUM BROMIDE 1273
3 METHOTREXATE SODIUM 1176
4 PREDNISONE 1080
5 ALBUTEROL SULFATE 1053
6 ETANERCEPT 1018
7 METHOTREXATE 1014
8 ADALIMUMAB 996
9 ASPIRIN 969
See all common drugs associated with LUNG NEOPLASM MALIGNANT

LUNG NEOPLASM MALIGNANT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BRIGATINIB 225 0.0616
1 RANITIDINE HYDROCHLORIDE 1963 0.0362
2 RANITIDINE 6760 0.0342
3 CRIZOTINIB 420 0.0330
4 ACLIDINIUM BROMIDE 191 0.0299
5 GLYCOPYRROLATE 163 0.0288
6 SOTORASIB 85 0.0245
7 INFLIXIMAB-DYYB 72 0.0209
8 ERGOCALCIFEROL 523 0.0176
9 GOLIMUMAB 215 0.0171
See all drugs enriched for association with LUNG NEOPLASM MALIGNANT

LUNG NEOPLASM MALIGNANT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 278 0.4041
1 Provitamin D2 Compound [EPC] 523 0.0176
2 Stimulant Laxative [EPC] 105 0.0073
3 Interleukin-17A Antagonist [EPC] 223 0.0060
4 Interleukin-23 Antagonist [EPC] 601 0.0057
5 Pyridone [EPC] 192 0.0047
6 Integrin Receptor Antagonist [EPC] 353 0.0041
7 PCSK9 Inhibitor [EPC] 98 0.0038
8 Factor Xa Inhibitor [EPC] 878 0.0032
9 Programmed Death Receptor-1 Blocking Antibody [EPC] 313 0.0032
See all drug classes enriched for association with LUNG NEOPLASM MALIGNANT